📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
WINDLAS BIOTECH LIMITEDWINDLASPharmaceuticals
Open
807.95
High
814.8
Low
779
Close
782.35
Volume
58538
Exchange
nse
Time
21-May-2026

Outlook

Score:

2.25

Rating:

RISKY

Candlestick Pattern

CandlepatternofWindlasBiotechis
Long Body
EstimatedStoplossofWindlasBiotechis
814.8
WindlasBiotechhasa
Bearishℹ
pattern.
Formationof
Long Body
candlepatternindicatesthetrenddirectionofWindlasBiotechmaybe
Unpredictableℹ
,butkeepalookoutforfallinprice.

Trend

WindlasBiotechisin
Sideways trendℹ
.
PriceofWindlasBiotechis
Downℹ
by

2.71

%.
Target
Buy@

687.69

Sell@

890.09

Current@

782.35

Volume

WindlasBiotechhasseena
Significantℹ
riseinvolumeoftrades.
ThevolumetrendforWindlasBiotechis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofWindlasBiotechis

Up

by

45.58

%

Valuation

ThecurrentmarketpriceofWindlasBiotechis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth760crandtotalassetsworth760cr,thebalancesheetofWindlasBiotechis:
Balancedℹ
.
Cashflow
WindlasBiotechhas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 4cr

.Itis
Downℹ
by

500

%.
47.55% i.e. ₹ 68cr earned in operatingℹ
51.75% i.e. ₹ 74cr spent in investingℹ
0.7% i.e. ₹ 1cr earned in financingℹ
0% in otherℹ
WindlasBiotechhas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 1cr

.Itis
Downℹ
by

66.67

%.
50.23% i.e. ₹ 108cr earned in operatingℹ
42.79% i.e. ₹ 92cr spent in investingℹ
6.98% i.e. ₹ 15cr spent in financingℹ
0% in otherℹ
Income
TheincomeofWindlasBiotechis

₹ 226cr

and

Profit

is:

₹ 17cr

WindlasBiotechProfitisupby:

6.25

%andIncomeisUpby:

3.86

%
TheincomeofWindlasBiotechis

₹ 215cr

and

Profit

is:

₹ 17cr

WindlasBiotechProfitisupby:

6.67

%andIncomeisUpby:

4.02

%
TheincomeofWindlasBiotechis

₹ 207cr

and

Profit

is:

₹ 16cr

WindlasBiotechProfitisupby:

0

%andIncomeisUpby:

4.19

%
By using this site you agree to the use of cookies to deliver a better site experience.